Branson Pharma develop a bio molecule that demonstrates a high efficacy and speed to eliminate a range of infections related to gynecologic conditions in uterus and fallopian tubes (endometritis, endometriosis, adenomyosis, etc.)
The molecule specifically targets infected cells only, dissolving dead and infected tissue by breaking any infection down into basic amino acids and removing them
Early tests demonstrated a significant efficacy closer to 100% treatment rate
At Branson Pharma we believe the final product can be called a cure
Cost effective to produce
We are now open to discuss co-investment options and to decide on locating future manufacuring in the EU
Investment
A biomolecule for treating life threatening women's health conditions
Branson Pharma develop a biomolecule to treat the most challenging gynaecology conditions - endometritis, endometriosis. The cure.